Opeyemi S Soremekun (Opeyemi Soremekun)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Molecular Dynamics Simulations

Respiratory Syndrome Coronavirus

Genome Wide Association Study

Top Venues

Current pharmaceutical biotechnology

Future science OA

This page only lists publications with an associated author ORCID identifier.

Publications

Opeyemi S Soremekun, Thobeka Mhlongwe, Gloria Kirabo, Callistus Akinyele, Tinashe Chikowore, Segun Fatumo, Dipender Gill
Genetically Proxied Lipid-Lowering Drug Target Perturbation and Ischemic Stroke Risk in European and African Ancestry Individuals: Mendelian Randomization Study. Stroke (2024)
Opeyemi S Soremekun, Thobeka Mhlongwe, Gloria Kirabo, Callistus Akinyele, Tinashe Chikowore, Segun Fatumo, Dipender Gill
Genetically Proxied Lipid-Lowering Drug Target Perturbation and Ischemic Stroke Risk in European and African Ancestry Individuals: Mendelian Randomization Study. Stroke 55 (7) (2024)
Opeyemi S Soremekun, Thobeka Mhlongwe, Gloria Kirabo, Callistus Akinyele, Tinashe Chikowore, Segun Fatumo, Dipender Gill
Genetically Proxied Lipid-Lowering Drug Target Perturbation and Ischemic Stroke Risk in European and African Ancestry Individuals: Mendelian Randomization Study. Stroke 55 (7) (2024)
Xylia Q Peters, Ghazi Elamin, Aimen Aljoundi, Mohamed Issa Alahmdi, Nader E Abo-Dya, Peter A Sidhom, Ahmed M Tawfeek, Mahmoud A A Ibrahim, Opeyemi S Soremekun, Mahmoud E S Soliman
Therapeutic Path to Triple Knockout: Investigating the Pan-inhibitory Mechanisms of AKT, CDK9, and TNKS2 by a novel 2-Phenylquinazolinone derivative in Cancer Therapy- An In-Silico Investigation. Current pharmaceutical biotechnology (2023)
Adeniyi T Adewumi, Opeyemi S Soremekun, Mary B Ajadi, Mahmoud E S Soliman
Thompson loop: opportunities for antitubercular drug design by targeting the weak spot in demethylmenaquinone methyltransferase protein. RSC advances 10 (39) (2020)
Opeyemi S Soremekun, Kehinde Foluke Omolabi, Adeniyi T Adewumi, Mahmoud E S Soliman
Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective. Future science OA 7 (1) (2020)